GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Fluvastatin capsules

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Lescol - labeled renal guidance

Product / population
Fluvastatin sodium (Lescol), oral capsule
Renal method
Renal impairment categories as defined by the cited product label
Source revision
DailyMed SPL version 1, posted Apr 05, 2011
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Lescol - product and source limitations

Confirm the immediate-release product and assess muscle symptoms and interacting drugs.

What to reconcile: Verify the current prescribing information for this presentation.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Lescol - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Fluvastatin sodium (Lescol), oral capsule

Renal method: Renal impairment categories as defined by the cited product label
Source date: DailyMed SPL version 1, posted Apr 05, 2011
Retrieved: 2026-11-07

Renal toxicity or monitoring. On-treatment injury and monitoring instructions are not a baseline renal-dose schedule.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: DOSAGE AND ADMINISTRATION

Exercise caution with fluvastatin doses above 40 mg in severe renal impairment because higher doses were not studied there. Confirm the immediate-release product and assess muscle symptoms and interacting drugs.

RDM74-lescol-official-1 · Source locator: Renal guidance: DOSAGE AND ADMINISTRATION

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e38126a5-9d6a-422f-812c-a01610108162
Retrieved
2026-11-07
Renal-function method
Renal impairment categories as defined by the cited product label
Source date/version
DailyMed SPL version 1, posted Apr 05, 2011
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
b6e03a3beb042980af0bbfcb87d169f839e74f1681189194b94b2eafd3879e53

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=general-fluvastatin&s1=RDM74-lescol-official&h1=0f546dc6e0b633e5206891009cd394902793571832b34e4c01a3519b7931c45e

Top